Evidence map›Paper›PMID 41600702›Full record

ReviewVeterinary sciences2026

The Beneficial Effects of Guanidinoacetic Acid as a Functional Feed Additive: A Possible Approach for Poultry Production.

Shaaban S Elnesr, Mohamed Shehab-El-Deen

Abstract readReview
In one paragraph

Review in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shaaban S ElnesrDepartment of Poultry Production, Faculty of Agriculture, Fayoum University, Fayoum 63514, Egypt.ORCID 0000-0002-4430-1492
Mohamed Shehab-El-DeenDepartment of Animal and Poultry Production, College of Agriculture and Food, Qassim University, Buraydah 52571, Al-Qassim, Saudi Arabia.ORCID 0000-0002-5707-2027

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional feed additives offer a viable strategy for producing sustainable and healthful poultry. Guanidinoacetic acid (GAA), a non-antibiotic growth stimulant, has attracted significant interest from both investors in the poultry sector and researchers due to its distinct biological properties and multiple potential applications. GAA facilitates creatine synthesis, accelerates metabolism, and boosts poultry growth. Consequently, GAA can be considered a safe and beneficial creatine substitute, as it is the sole natural precursor of creatine. GAA meets the livestock industry's demand for safe and effective therapies because it is non-toxic, readily degradable, and leaves no residues. Additionally, GAA is more stable and economical than creatine, making it a superior feed additive. In broiler chicks, GAA can replace arginine in practical diets containing either adequate or deficient levels of arginine. Supplementation with GAA offers promising opportunities to optimize broiler production and general health by promoting energy metabolism and protein synthesis. Commercially available feed-grade GAA has a high potential for inclusion in broiler diets. Supplementing broiler chickens with GAA may be an effective approach to improve performance parameters such as body weight and feed conversion ratio. In conclusion, dietary GAA supplementation (approximately 0.6-1.2 g/kg of diet, depending on desired impacts) can improve the productive performance of poultry. This review updates current knowledge on the impacts of GAA on productive and reproductive performance, egg quality, digestibility, antioxidant indices, and gut health in poultry.

Indexed as

antioxidantdietary supplementshealthperformancepoultry

Identifiers

PMID41600702
PMCPMC12846419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.